{"transactions":[{"id":793455,"issuer":{"id":4476,"kind":"organization","name":"Hemab Therapeutics Holdings, Inc.","symbol":"COAG"},"owners":[{"id":49881,"kind":"person","name":"Madigan Catherine","position":1,"cik":"0001914577","reported_name":"Madigan Catherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T20:18:33.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":49016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 30, 2026. The shares underlying the option will vest over four years in equal monthly installments from May 1, 2026 through May 1, 2030."}],"balance_after":49016,"derivative":{"exercise_price":18,"expiration_date":"2036-04-29","underlying":"Common Stock","underlying_shares":49016},"source":{"system":"sec-edgar","filing":"0001193125-26-204041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1914577/000119312526204041/ownership.xml","form_type":"4"}},{"id":793454,"issuer":{"id":4476,"kind":"organization","name":"Hemab Therapeutics Holdings, Inc.","symbol":"COAG"},"owners":[{"id":49881,"kind":"person","name":"Madigan Catherine","position":1,"cik":"0001914577","reported_name":"Madigan Catherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2026-05-04T20:18:33.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":145134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrant was granted on January 29, 2026. The shares underlying the warrant vest over four years, with 25% of the shares vesting on January 1, 2027 and the remaining shares vesting in equal monthly installments thereafter."}],"balance_after":145134,"derivative":{"exercise_price":6,"expiration_date":"2036-01-28","underlying":"Common Stock","underlying_shares":145134},"source":{"system":"sec-edgar","filing":"0001193125-26-204041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1914577/000119312526204041/ownership.xml","form_type":"4"}},{"id":2032321,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":49881,"kind":"person","name":"Madigan Catherine","position":1,"cik":"0001914577","reported_name":"Madigan Catherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-02-03T22:01:12.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":110000,"price":28.55,"value":3140500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest monthly over a four-year period."}],"balance_after":110000,"derivative":{"exercise_price":28.55,"expiration_date":"2033-02-02","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001562180-23-000954","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218023000954/primarydocument.xml","form_type":"4"}},{"id":2353298,"issuer":{"id":4578,"kind":"organization","name":"Syndax Pharmaceuticals Inc"},"owners":[{"id":49881,"kind":"person","name":"Madigan Catherine","position":1,"cik":"0001914577","reported_name":"Madigan Catherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-03T21:24:05.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":180000,"price":16.06,"value":2890800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the total number of shares\nunderlying the option shall vest on March 1, 2023, and\none-thirty-sixth (1/36th) of the remaining shares underlying the option\nshall vest monthly thereafter on the last day of each month, subject to\nthe reporting person's continuous service on the relevant vesting dates."}],"balance_after":180000,"derivative":{"exercise_price":16.06,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001562180-22-002258","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395937/000156218022002258/primarydocument.xml","form_type":"4"}}]}